About the Cancer and Rare Genetic Disorders Session
Cancer and rare genetic disorders are an emerging area of research, as certain rare genetic conditions predispose individuals to specific types of cancer. Syndromes such as Li-Fraumeni syndrome, Lynch syndrome, and Fanconi anemia, which are caused by inherited mutations in tumor suppressor genes or repair genes, increase the risk of developing a variety of cancers at an early age. Cancer research is focused on identifying the genetic mutations that contribute to these rare disorders and understanding how they promote cancer development. Researchers are also looking into precision therapies that target the underlying genetic defects, which could provide more effective treatments for individuals with rare genetic disorders and their associated cancers.
Topics Covered in Cancer and Rare Genetic Disorders
Tumor Suppressor Syndromes
Bone Marrow Failure Syndromes
Early-Onset Cancers
Predisposition Testing
Tailored Surveillance
Genotype-Guided Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer and Rare Genetic Disorders Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer and Rare Genetic Disorders work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer and Rare Genetic Disorders research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer and Rare Genetic Disorders track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer and Rare Genetic Disorders Conference 2027 — FAQs
What is the Cancer and Rare Genetic Disorders track at CIOC 2027?
The Cancer and Rare Genetic Disorders track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer and Rare Genetic Disorders. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer and Rare Genetic Disorders sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer and Rare Genetic Disorders are all welcome — whether presenting or attending.
Can I present my research in the Cancer and Rare Genetic Disorders track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer and Rare Genetic Disorders sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer and Rare Genetic Disorders track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.